Skip to main content

Closed

OGEN: Oragenics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-126.0%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-16.2×

Current ratio133.42×

Oragenics, Inc.

OGENNew York Stock Exchange Arca·USD·Closed

Oragenics, Inc.

OGENNew York Stock Exchange Arca·USD·Closed

$0.55

+3.91%

$0.55

+$0.02 (3.91%)

52W Range

7thpctl

Volume

0.54×avg

Mkt Cap

2.48MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.54×avg

Market Cap

2.48MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings